Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-020607
Filing Date
2025-02-14
Accepted
2025-02-14 10:56:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10525
  Complete submission text file 0000950170-25-020607.txt   12601
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Subject) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91725 | Film No.: 25624834
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 300 TURNEY STREET SAUSALITO CA 94965
Business Address 300 TURNEY STREET SAUSALITO CA 94965 415-706-8852
REVELATION HEALTHCARE FUND I, L.P. (Filed by) CIK: 0001612448 (see all company filings)

EIN.: 611729043 | State of Incorp.: DE
Type: SCHEDULE 13G/A